We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.06B
AUM Growth
+$126M
Cap. Flow
+$31.9M
Cap. Flow %
3.01%
Top 10 Hldgs %
50.38%
Holding
252
New
48
Increased
91
Reduced
75
Closed
18

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.2%
2 Technology 5.81%
3 Healthcare 1.72%
4 Financials 1.08%
5 Communication Services 0.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RY icon
176
Royal Bank of Canada
RY
$283B
$288K 0.03%
+2,849
New +$251K
RCL icon
177
Royal Caribbean
RCL
$74.7B
$288K 0.03%
+2,221
New +$226K
TGT icon
178
Target
TGT
$74.1B
$287K 0.03%
2,017
-178
-8% -$21.7K
UNP icon
179
Union Pacific
UNP
$183B
$283K 0.03%
1,151
-109
-9% -$24K
TTE icon
180
TotalEnergies
TTE
$191B
$283K 0.03%
+4,195
New +$280K
VTI icon
181
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
$278K 0.03%
1,171
+1
+0.1% +$221
ARM icon
182
Arm
ARM
$255B
$271K 0.03%
+3,606
New +$211K
SPEM icon
183
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.8B
$266K 0.03%
7,512
+33
+0.4% +$1.12K
SCHW
184
Charles Schwab
SCHW
$191B
$265K 0.03%
+3,853
New +$223K
VUG icon
185
Vanguard Morningstar Growth ETF
VUG
$228B
$264K 0.02%
5,100
TLTD icon
186
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$690M
$264K 0.02%
3,867
+32
+0.8% +$2.04K
SONY icon
187
Sony
SONY
$145B
$262K 0.02%
+13,820
New +$240K
PSTX
188
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$257K 0.02%
76,559
WEC icon
189
WEC Energy
WEC
$34.6B
$255K 0.02%
3,035
-1,217
-29% -$100K
ED icon
190
Consolidated Edison
ED
$39.8B
$248K 0.02%
2,726
+305
+13% +$27.2K
IG icon
191
Principal Investment Grade Corporate Active ETF
IG
$202M
$247K 0.02%
11,762
ILMN icon
192
Illumina
ILMN
$32.6B
$244K 0.02%
1,798
-486
-21% -$56.1K
PYPL icon
193
PayPal
PYPL
$45.9B
$243K 0.02%
3,960
+215
+6% +$12.3K
NKE icon
194
Nike
NKE
$58.7B
$240K 0.02%
+2,213
New +$238K
IDYA icon
195
IDEAYA Biosciences
IDYA
$3.87B
$239K 0.02%
+6,726
New +$201K
BUD icon
196
AB InBev
BUD
$158B
$239K 0.02%
+3,695
New +$218K
FITB
197
Fifth Third Bancorp
FITB
$49.5B
$236K 0.02%
+6,852
New +$190K
RSPT icon
198
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.89B
$236K 0.02%
7,240
DB icon
199
Deutsche Bank
DB
$75.8B
$231K 0.02%
17,023
+6,264
+58% +$73.7K
QCOM icon
200
Qualcomm
QCOM
$175B
$229K 0.02%
1,587
-2,847
-64% -$353K

Similar funds

Callan Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Callan Capital held 252 positions worth $1.06B, up 13% from $934M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Callan Capital deployed $31.9M of net new capital in Q4 2023, opening 48 new positions and adding to 91 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 36,225 shares worth $2.09M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 90% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Innovative Industrial Properties, an estimated $2.65M trimmed.

  • Callan Capital's largest Q4 2023 buy was Avantis US Large Cap Value ETF: 36,225 shares worth $2.09M.
  • Callan Capital added most to NVIDIA in Q4 2023, an estimated $11.4M increase.
  • Callan Capital's biggest Q4 2023 reduction was Innovative Industrial Properties, cutting an estimated $2.65M.
  • Callan Capital fully exited Fortinet in Q4 2023, selling an estimated $3.07M.
  • Callan Capital's ten largest holdings make up 50% of its $1.06B portfolio in Q4 2023.
  • Callan Capital opened 48 new positions and closed 18 in Q4 2023.
  • Callan Capital's portfolio value rose 13% quarter-over-quarter to $1.06B.

Based on Callan Capital's 13F filing for Q4 2023, filed 2 Feb 2024.